NewEdge Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,941
Closed -$293K 889
2019
Q3
$293K Buy
2,941
+308
+12% +$29.3K 0.01% 643
2019
Q2
$243K Sell
2,633
-109
-4% -$10.4K 0.01% 572
2019
Q1
$259K Sell
2,742
-3,108
-53% -$272K 0.02% 563
2018
Q4
$375 Buy
5,850
+1,473
+34% +$109K 0.02% 435
2018
Q3
$392K Buy
4,377
+875
+25% +$77.3K 0.03% 425
2018
Q2
$278 Buy
+3,502
New +$291K 0.03% 430
2017
Q4
Sell
-1,534
Closed -$214K 434
2017
Q3
$214K Buy
1,534
+1,204
+365% +$164K 0.03% 344
2017
Q2
$43.5K Buy
+330
New +$40.4K 0.01% 557

Other funds holding CELG

NewEdge Advisors's CELG Position: Q4 2019 in Review

NewEdge Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,941 shares — an estimated $293K sold.

NewEdge Advisors first reported a position in CELG in Q2 2017 and held it in 8 quarters. The position peaked at $392K in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • NewEdge Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • NewEdge Advisors sold 2,941 Celgene Corp shares in Q4 2019, an estimated $293K.
  • NewEdge Advisors first reported a position in Celgene Corp in Q2 2017 and held it in 8 quarters.
  • NewEdge Advisors's Celgene Corp position peaked at $392K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on NewEdge Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.